革命性瘤学:人工智能 (AI) 作为抗体设计的作用,以及优化工具
Varun Dewaker1, Vivek Kumar Morya2, Yoo Hee Kim3
1Institute of New Frontier Research Team, Hallym University, Chuncheon-Si, Gangwon-Do, 24252, Republic of Korea.
Biomarker research
|March 29, 2025
概括
人工智能 (AI) 正在彻底改变抗体的发现和设计. 人工智能加速新型抗体的产生,提高免疫反应的精度,并优化治疗癌症等疾病的疗效.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 计算生物学 计算生物学
背景情况:
- 抗体对于对抗癌症等疾病的免疫防御至关重要.
- 抗体技术已经从单克隆抗体 (mAbs) 演变为CAR-T细胞.
- 人工智能 (AI) 集成正在改变抗体设计和优化.
研究的目的:
- 审查最近在抗体发现和设计方面的人工智能进展.
- 突出AI在加速新抗体生成和优化治疗疗效方面的作用.
- 讨论AI对预测抗体序列,结构和相互作用的影响.
主要方法:
- 审查最近的AI进展,包括大语言模型 (LLM),扩散模型和生成AI.
- 在预测抗体序列,3D结构,CDRs,paratopes,epitopes和抗原-抗体相互作用方面分析AI应用.
- 整合计算进步与生物医学应用用于抗体开发.
主要成果:
- 人工智能显著加快了新的抗体生成,并提高了免疫反应的精度.
- 人工智能通过提高抗体设计的速度,特异性和准确性来优化治疗疗效.
- 由人工智能驱动的工具可以预测和设计关键的抗体组件和相互作用.
结论:
- 人工智能正在彻底改变抗体发现,解决发展中的长期挑战.
- 人工智能集成正在推动下一代癌症疗法和精准医学.
- 人工智能驱动的抗体设计有望增强治疗干预和改善患者的治疗结果.
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.